Search
for
Sort by
Research 211–240 of 1000+
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- 5α-Reduced glucocorticoids: a story of natural selection
- A preliminary study of finasteride in Tourette syndrome
- Systematic approach to hair loss in women
- Cicatricial (Scarring) Alopecias
- Chemotherapy-induced alopecia
- Hair cosmetics
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Prenatal serological diagnosis of intrauterine cytomegalovirus infection.
- Prediction of male-pattern baldness from genotypes
- Trichoscopy in Hair Shaft Disorders
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Syphilis: A great imitator
- A Nonrandomized study of trichoscopy patterns using nonpolarized (contact) and polarized (noncontact) dermatoscopy in hair and shaft disorders
- Hydrogen peroxide and monoethanolamine are the key causative ingredients for hair dye-induced dermatitis and hair loss
- Dermoscopy of scalp tumours: a multi‐centre study conducted by the international dermoscopy society
- Treatment strategies for alopecia
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Peppermint Oil Promotes Hair Growth without Toxic Signs
- Dermoscopy Research—An Update
- Parkinson's disease and skin
- Role of β-Catenin Activation Levels and Fluctuations in Controlling Cell Fate
- Lupus panniculitis clinically simulating alopecia areata
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Hair removal using a long-pulsed alexandrite laser.
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis